Reuters -- Japan's Takeda Pharmaceutical Co (4502.T) used a misleading promotion for its insomnia drug Rozerem, U.S. regulators said in a letter released on Friday.
Reuters -- Japan's Takeda Pharmaceutical Co (4502.T) used a misleading promotion for its insomnia drug Rozerem, U.S. regulators said in a letter released on Friday.